Xavier Guille des Buttes
Director/Board Member at GENFIT
Net worth: 6 303 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jean-François Mouney | M | 68 | 25 years | |
| Franck Zal | M | - |
Hemarina SA
 Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | 17 years |
| Catherine Larue | M | 68 | 7 years | |
| Stefanie Magner | F | 43 | 8 years | |
| Laurent Lannoo | M | 54 | 16 years | |
| Jean-François Tiné | M | 67 | 3 years | |
| Pascal Caisey | M | 56 | 5 years | |
| Eric Baclet | M | 64 | 4 years | |
| Pascal Prigent | M | 56 | 6 years | |
| Katherine Kalin | F | 61 | 4 years | |
| Jean-Christophe Marcoux | M | 47 | 9 years | |
| Anne-Hélène Monsellato | F | 56 | 7 years | |
| Olivier Legrain | M | 56 |
IBA Molecular Holding SA
 IBA Molecular Holding SA Pharmaceuticals: MajorHealth Technology IBA Molecular Holding SA develops and markets leading edge technologies, pharmaceuticals and tailor made solutions for healthcare with a focus on cancer diagnosis and therapy. The firm serves the medical and healthcare industries. The company is headquartered in Louvain-la-Neuve, Belgium. | 20 years |
| Dean Hum | M | 61 | 24 years | |
| Pierre Mottet | M | 63 |
IBA Molecular Holding SA
IBA Molecular Holding SA Pharmaceuticals: MajorHealth Technology IBA Molecular Holding SA develops and markets leading edge technologies, pharmaceuticals and tailor made solutions for healthcare with a focus on cancer diagnosis and therapy. The firm serves the medical and healthcare industries. The company is headquartered in Louvain-la-Neuve, Belgium. | - |
| Florence Séjourné | F | 52 | 25 years | |
| Emilie Lidome | F | 41 |
Hemarina SA
Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | - |
| Soumya Chandramouli | F | 46 |
IBA Molecular Holding SA
IBA Molecular Holding SA Pharmaceuticals: MajorHealth Technology IBA Molecular Holding SA develops and markets leading edge technologies, pharmaceuticals and tailor made solutions for healthcare with a focus on cancer diagnosis and therapy. The firm serves the medical and healthcare industries. The company is headquartered in Louvain-la-Neuve, Belgium. | 7 years |
| Meriam Kabbaj | M | 50 | 2 years | |
| Patrick Franchet | M | - |
Hemarina SA
Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | - |
| Christian Grenier | M | - |
Delpharm SAS
 Delpharm SAS Pharmaceuticals: MajorHealth Technology Delpharm SAS develops and manufactures drugs. The company is headquartered in Issy-les-Moulineaux, France. | - |
| Carol L. Addy | M | 64 | 5 years | |
| Helene Delecourt | F | - |
Hemarina SA
Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | - |
| Thomas Baetz | M | 50 | 3 years | |
| John Brozek | M | 47 | - | |
| Émilie Desodt | F | 41 | 6 years | |
| Stephanie Boyer | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Nathalie Huitorel | F | 62 | 14 years | |
| Charles Woler | M | 74 | 11 years | |
| Frédéric Joël Desdouits | M | 57 | - | |
| Patrick Jeanmart | M | 51 |
IBA Molecular Holding SA
IBA Molecular Holding SA Pharmaceuticals: MajorHealth Technology IBA Molecular Holding SA develops and markets leading edge technologies, pharmaceuticals and tailor made solutions for healthcare with a focus on cancer diagnosis and therapy. The firm serves the medical and healthcare industries. The company is headquartered in Louvain-la-Neuve, Belgium. | 3 years |
| Philippe Moons | M | 72 | 21 years | |
| Raphaël Darteil | M | - | - | |
| Sophie Mégnien | M | - | - | |
| Steven Hildemann | M | - | - | |
| Philippe Motté | M | 64 | 2 years | |
| Alice Roudot-Ketelers | M | 53 | - | |
| Pascal Birman | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 34 | 89.47% |
| Belgium | 4 | 10.53% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Xavier Guille des Buttes
- Personal Network
